Corvus Pharmaceuticals, Inc.

8-K Director or officer change Jul 22, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Regulation FD disclosure; Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 23, 2026 8-K Entered a material agreement Mar 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Other events Jan 23, 2026 8-K Other events Jan 20, 2026 8-K Regulation FD disclosure; Other events Jan 20, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change Oct 2, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Regulation FD disclosure; Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 8, 2025 8-K Director or officer change Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Regulation FD disclosure; Other events Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 18, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement Oct 23, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Entered a material agreement May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Other events May 1, 2024 10-K Fiscal year ended 2023-12-31 Mar 19, 2024 8-K Results of operations (earnings release) Mar 19, 2024 8-K Director or officer change; Other events Jan 23, 2024 8-K Results of operations (earnings release) Nov 7, 2023